Загрузка...
The GIST of Targeted Therapy for Malignant Melanoma
The high response rates to the tyrosine kinase inhibitor imatinib in KIT-mutated gastrointestinal stromal tumors (GIST) has led to a paradigm shift in cancer treatment. In a parallel fashion, the field of melanoma is shifting with the utilization of targeted therapy to treat BRAF-mutated melanoma. W...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4041068/ https://ncbi.nlm.nih.gov/pubmed/24531699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-013-3373-z |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|